Combining sonodynamic therapy with chemoradiation for the treatment of pancreatic cancer
- PMID: 34274382
- DOI: 10.1016/j.jconrel.2021.07.020
Combining sonodynamic therapy with chemoradiation for the treatment of pancreatic cancer
Abstract
Treatment options for patients with pancreatic cancer are limited and survival prospects have barely changed over the past 4 decades. Chemoradiation treatment (CRT) has been used as neoadjuvant therapy in patients with borderline resectable disease to reduce tumour burden and increase the proportion of patients eligible for surgery. Antimetabolite drugs such as gemcitabine and 5-fluorouracil are known to sensitise pancreatic tumours to radiation treatment. Likewise, photodynamic therapy (PDT) has also been shown to enhance the effect of radiation therapy. However, PDT is limited to treating superficial lesions due to the attenuation of light by tissue. The ability of the related technique, sonodynamic therapy (SDT), to enhance CRT was investigated in two murine models of pancreatic cancer (PSN-1 and BxPC-3) in this study. SDT uses low intensity ultrasound to activate an otherwise non-toxic sensitiser, generating toxic levels of reactive oxygen species (ROS) locally. It is applicable to greater target depths than PDT due to the ability of ultrasound to propagate further than light in tissue. Both CRT and the combination of CRT plus SDT delayed tumour growth in the two tumour models. In the PSN-1 model, but not the BxPC-3 model, the combination treatment caused an increase in survival relative to CRT alone (p = 0.038). The improvement in survival conferred by the addition of SDT in this model may be related to differences in tumour architecture between the two models. MRI and US images showed that PSN-1 tumours were less well perfused and vascularised than BxPC-3 tumours. This poor vascularisation may explain why PSN-1 tumours were more susceptible to the effects of vascular damage exerted by SDT treatment.
Keywords: Chemoradiotherapy; Oxygen microbubbles; Pancreatic cancer; Sonodynamic therapy; Ultrasound.
Copyright © 2021. Published by Elsevier B.V.
Similar articles
-
Combined sonodynamic and antimetabolite therapy for the improved treatment of pancreatic cancer using oxygen loaded microbubbles as a delivery vehicle.Biomaterials. 2016 Feb;80:20-32. doi: 10.1016/j.biomaterials.2015.11.033. Epub 2015 Nov 26. Biomaterials. 2016. PMID: 26702983
-
Comparing the efficacy of photodynamic and sonodynamic therapy in non-melanoma and melanoma skin cancer.Bioorg Med Chem. 2016 Jul 1;24(13):3023-3028. doi: 10.1016/j.bmc.2016.05.015. Epub 2016 May 12. Bioorg Med Chem. 2016. PMID: 27234890
-
Exploiting a Rose Bengal-bearing, oxygen-producing nanoparticle for SDT and associated immune-mediated therapeutic effects in the treatment of pancreatic cancer.Eur J Pharm Biopharm. 2021 Jun;163:49-59. doi: 10.1016/j.ejpb.2021.03.005. Epub 2021 Mar 31. Eur J Pharm Biopharm. 2021. PMID: 33798727
-
Treating cancer with sonodynamic therapy: a review.Int J Hyperthermia. 2015 Mar;31(2):107-17. doi: 10.3109/02656736.2014.992484. Epub 2015 Jan 13. Int J Hyperthermia. 2015. PMID: 25582025 Review.
-
Sonodynamic Therapy: Concept, Mechanism and Application to Cancer Treatment.Adv Exp Med Biol. 2016;880:429-50. doi: 10.1007/978-3-319-22536-4_22. Adv Exp Med Biol. 2016. PMID: 26486350 Review.
Cited by
-
Biomimetic cytomembrane-coated ZIF-8-loaded DMDD nanoparticle and sonodynamic co-therapy for cancer.Ann Transl Med. 2022 Sep;10(18):971. doi: 10.21037/atm-22-3646. Ann Transl Med. 2022. PMID: 36267767 Free PMC article.
-
Non-Viral Delivery of CRISPR/Cas Cargo to the Retina Using Nanoparticles: Current Possibilities, Challenges, and Limitations.Pharmaceutics. 2022 Sep 1;14(9):1842. doi: 10.3390/pharmaceutics14091842. Pharmaceutics. 2022. PMID: 36145593 Free PMC article. Review.
-
Sonodynamic therapy: Rapid progress and new opportunities for non-invasive tumor cell killing with sound.Cancer Lett. 2022 Apr 28;532:215592. doi: 10.1016/j.canlet.2022.215592. Epub 2022 Feb 11. Cancer Lett. 2022. PMID: 35151824 Free PMC article. Review.
-
Latest Advances in the Use of Therapeutic Focused Ultrasound in the Treatment of Pancreatic Cancer.Cancers (Basel). 2022 Jan 27;14(3):638. doi: 10.3390/cancers14030638. Cancers (Basel). 2022. PMID: 35158903 Free PMC article. Review.
-
Sonodynamic Therapy of NRP2 Monoclonal Antibody-Guided MOFs@COF Targeted Disruption of Mitochondrial and Endoplasmic Reticulum Homeostasis to Induce Autophagy-Dependent Ferroptosis.Adv Sci (Weinh). 2023 Oct;10(30):e2303872. doi: 10.1002/advs.202303872. Epub 2023 Sep 3. Adv Sci (Weinh). 2023. PMID: 37661565 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous